Premium
Long‐term results of a self‐expanding wallstent in the treatment of urethral stricture
Author(s) -
Hussain Mahreen,
Greenwell Tamsin J.,
Shah Julian,
Mundy Anthony
Publication year - 2004
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/j.1464-410x.2004.05100.x
Subject(s) - medicine , urethral stricture , surgery , stent , urethrotomy , urethroplasty , etiology , lower urinary tract symptoms , catheter , urethra , prostate , cancer
OBJECTIVE To report the long‐term outcome over 12 years of using the urethral Urolume TM wallstent (AMS, Minnetonka, MI, USA) for treating recurrent bulbar urethral stricture disease. PATIENTS AND METHODS The case‐notes of 60 consecutive men with urethral Urolume wallstents placed for treating recurrent bulbar strictures were reviewed retrospectively. Information was collected on patient demographics, stricture aetiology, stent‐related complications and the need for further surgery to treat stent‐ or stricture‐related complications. RESULTS The mean (range) age of the men was 58 (32–76) years. The most common cause of stricture was iatrogenic, arising after previous endoscopic surgery or after an indwelling catheter (45%). Thirty‐five men had complications, with re‐operation required in 27 (45%) of them. The most frequent nonsurgical complications were post‐micturition dribble (32%) and recurrent urinary tract infections (27%). The most common surgical interventions required were transurethral resection of obstructing stent hyperplasia (32%), urethral dilatation or urethrotomy for stent obstruction or stricture (25%) and endoscopic litholapaxy for stent encrustation or stone (17%). CONCLUSIONS The Urolume wallstent should only be used in patients who are unfit for or who refuse a bulbar urethroplasty.